Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CRDF - Cardiff Oncology announces departure of medical chief

CRDF - Cardiff Oncology announces departure of medical chief

Cardiff Oncology Inc.
Cardiff Oncology (NASDAQ:CRDF) shares are trading lower in the post-market Tuesday after the cancer-focused biotech announced that its chief medical officer (CMO) Katherine L. Ruffner would leave the company effective Apr. 22 to pursue a new opportunity. However, Dr. Ruffner has agreed to support the company’s operations temporarily, Cardiff Oncology (CRDF) said, adding that Sandra L. Silberman, a former chief medical advisor to the company, will serve as senior medical advisor on an interim basis. Dr. Silberman, who currently functions as the chief medical officer for Moleculin Biotech and CNS Pharmaceuticals, will therefore oversee the clinical trials and clinical operations team, Cardiff Oncology (CRDF) said. "On behalf of the entire Cardiff Oncology team, I would like to thank Katherine for her contributions to the Company and wish her well in her next endeavor," Chief Executive Mark Erlander remarked.

For further details see:

Cardiff Oncology announces departure of medical chief
Stock Information
Company Name: Cardiff Oncology Inc.
Stock Symbol: CRDF
Market: NASDAQ
Website: cardiffoncology.com
Menu
CRDF CRDF Quote CRDF Short CRDF News CRDF Articles CRDF Message Board
Get CRDF Alerts

News, Short Squeeze, Breakout and More Instantly...